- Home
- FDS vs PODD Comparison
FDS vs PODD Comparison
Compare FDS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDS
- PODD
- Stock Information
- Founded
- FDS 1978
- PODD 2000
- Country
- FDS United States
- PODD United States
- Employees
- FDS N/A
- PODD N/A
- Industry
- FDS Computer Software: Programming Data Processing
- PODD Medical/Dental Instruments
- Sector
- FDS Technology
- PODD Health Care
- Exchange
- FDS Nasdaq
- PODD Nasdaq
- Market Cap
- FDS 17.5B
- PODD 17.2B
- IPO Year
- FDS 1996
- PODD 2007
- Fundamental
- Price
- FDS $448.67
- PODD $257.00
- Analyst Decision
- FDS Sell
- PODD Buy
- Analyst Count
- FDS 9
- PODD 17
- Target Price
- FDS $443.44
- PODD $302.56
- AVG Volume (30 Days)
- FDS 242.1K
- PODD 695.5K
- Earning Date
- FDS 06-20-2025
- PODD 05-08-2025
- Dividend Yield
- FDS 0.98%
- PODD N/A
- EPS Growth
- FDS 11.45
- PODD 96.55
- EPS
- FDS 14.08
- PODD 5.78
- Revenue
- FDS $2,254,222,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- FDS $6.03
- PODD $20.53
- Revenue Next Year
- FDS $5.86
- PODD $17.42
- P/E Ratio
- FDS $31.86
- PODD $44.43
- Revenue Growth
- FDS 4.66
- PODD 22.07
- 52 Week Low
- FDS $391.69
- PODD $160.19
- 52 Week High
- FDS $499.87
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- FDS 60.43
- PODD 50.41
- Support Level
- FDS $424.99
- PODD $252.88
- Resistance Level
- FDS $437.99
- PODD $260.96
- Average True Range (ATR)
- FDS 9.33
- PODD 7.68
- MACD
- FDS 2.78
- PODD 1.34
- Stochastic Oscillator
- FDS 90.64
- PODD 65.40
About FDS FactSet Research Systems Inc.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.